FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1900410293> ?p ?o ?g. }

• W1900410293 endingPage "20069" @default.
• W1900410293 startingPage "20058" @default.
• W1900410293 abstract "// Marco Scarpa 1, * , Paola Brun 2, * , Melania Scarpa 1 , Susan Morgan 3 , Andrea Porzionato 2 , Andromachi Kotsafti 1 , Marina Bortolami 4 , Andrea Buda 4 , Renata D’Incà 4 , Veronica Macchi 2 , Giacomo C. Sturniolo 4 , Massimo Rugge 5 , Romeo Bardini 4 , Ignazio Castagliuolo 2 , Imerio Angriman 4, § , Carlo Castoro 1, § 1 Oncological Surgery Unit, Veneto Institute of Oncology IOV – IRCCS, Padova 35128, Italy 2 Department of Molecular Medicine, University of Padova, Padova 35128, Italy 3 Department of Histopathology, Sheffield Teaching Hospitals, Sheffield S10 2JF, UK 4 Department of Surgery Oncology and Gastroenterology, University of Padova, Padova 35128, Italy 5 Department of Medicine, University of Padova, Padova 35128, Italy * These authors have contributed equally to this work § These senior authors contributed equally to this work Correspondence to: Marco Scarpa, e-mail: marcoscarpa73@yahoo.it Keywords: ulcerative colitis, colorectal carcinogenesis, antigen presenting cells, CD8+ T cells, intestinal epithelial cells Received: September 18, 2014      Accepted: November 19, 2014      Published: January 19, 2015 ABSTRACT In patients with ulcerative colitis (UC) the cumulative risk of colon cancer is lower than the actual rate of dysplasia suggesting an efficient immune surveillance mechanism. Since the co-stimulatory molecule CD80 is overexpressed in dysplastic colonic mucosa of UC patients and T-cell activation entails effective costimulation, we aimed to evaluate the functional implication of CD80 signaling in colonic UC-associated carcinogenesis. In humans, we observed that the percentage of CD80+ and HLA-A+ IEC was increased in the dysplastic colonic mucosa of UC patients. In vitro , IEC activated CD8+ T-cells through a CD80-dependent pathway. Finally, in the AOM/DSS-induced colonic adenocarcinoma model CD80 signaling inhibition significantly increased the frequency and extension of high-grade dysplasia, whereas enhancing CD80 activity with an anti-CTLA4 antibody significantly decreased colonic dysplasia. In conclusion, CD80 signaling between IEC and T-cells represents a key factor controlling the progression from low to high grade dysplasia in inflammatory colonic carcinogenesis." @default.
• W1900410293 created "2016-06-24" @default.
• W1900410293 creator A5000666523 @default.
• W1900410293 creator A5004814157 @default.
• W1900410293 creator A5015771184 @default.
• W1900410293 creator A5025296279 @default.
• W1900410293 creator A5034239187 @default.
• W1900410293 creator A5035662512 @default.
• W1900410293 creator A5042040126 @default.
• W1900410293 creator A5043839163 @default.
• W1900410293 creator A5049281397 @default.
• W1900410293 creator A5049641939 @default.
• W1900410293 creator A5061145127 @default.
• W1900410293 creator A5063425002 @default.
• W1900410293 creator A5070038178 @default.
• W1900410293 creator A5071335044 @default.
• W1900410293 creator A5076722892 @default.
• W1900410293 creator A5083608720 @default.
• W1900410293 date "2015-01-16" @default.
• W1900410293 modified "2023-10-18" @default.
• W1900410293 title "CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis" @default.
• W1900410293 cites W1483194800 @default.
• W1900410293 cites W1608422746 @default.
• W1900410293 cites W1836596473 @default.
• W1900410293 cites W1968097840 @default.
• W1900410293 cites W1976721329 @default.
• W1900410293 cites W1978416272 @default.
• W1900410293 cites W1980474981 @default.
• W1900410293 cites W1983732160 @default.
• W1900410293 cites W1989914829 @default.
• W1900410293 cites W1994152080 @default.
• W1900410293 cites W2016776347 @default.
• W1900410293 cites W2028025555 @default.
• W1900410293 cites W2029208213 @default.
• W1900410293 cites W2032466777 @default.
• W1900410293 cites W2037449100 @default.
• W1900410293 cites W2037626742 @default.
• W1900410293 cites W2046972425 @default.
• W1900410293 cites W2052299904 @default.
• W1900410293 cites W2052313621 @default.
• W1900410293 cites W2062889582 @default.
• W1900410293 cites W2066671159 @default.
• W1900410293 cites W2081845410 @default.
• W1900410293 cites W2087225754 @default.
• W1900410293 cites W2090836203 @default.
• W1900410293 cites W2093293871 @default.
• W1900410293 cites W2094366129 @default.
• W1900410293 cites W2096151993 @default.
• W1900410293 cites W2097733438 @default.
• W1900410293 cites W2102579281 @default.
• W1900410293 cites W2120663521 @default.
• W1900410293 cites W2121988130 @default.
• W1900410293 cites W2123895023 @default.
• W1900410293 cites W2130503272 @default.
• W1900410293 cites W2142300779 @default.
• W1900410293 cites W2151439603 @default.
• W1900410293 cites W2153178471 @default.
• W1900410293 cites W2154391127 @default.
• W1900410293 cites W2160598672 @default.
• W1900410293 cites W2165581505 @default.
• W1900410293 cites W2169999570 @default.
• W1900410293 cites W2170312093 @default.
• W1900410293 cites W2171190137 @default.
• W1900410293 cites W2325101317 @default.
• W1900410293 cites W2560367415 @default.
• W1900410293 doi "https://doi.org/10.18632/oncotarget.2780" @default.
• W1900410293 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4652987" @default.
• W1900410293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25595911" @default.
• W1900410293 hasPublicationYear "2015" @default.
• W1900410293 type Work @default.
• W1900410293 sameAs 1900410293 @default.
• W1900410293 citedByCount "22" @default.
• W1900410293 countsByYear W19004102932015 @default.
• W1900410293 countsByYear W19004102932016 @default.
• W1900410293 countsByYear W19004102932017 @default.
• W1900410293 countsByYear W19004102932018 @default.
• W1900410293 countsByYear W19004102932019 @default.
• W1900410293 countsByYear W19004102932020 @default.
• W1900410293 countsByYear W19004102932021 @default.
• W1900410293 countsByYear W19004102932022 @default.
• W1900410293 countsByYear W19004102932023 @default.
• W1900410293 crossrefType "journal-article" @default.
• W1900410293 hasAuthorship W1900410293A5000666523 @default.
• W1900410293 hasAuthorship W1900410293A5004814157 @default.
• W1900410293 hasAuthorship W1900410293A5015771184 @default.
• W1900410293 hasAuthorship W1900410293A5025296279 @default.
• W1900410293 hasAuthorship W1900410293A5034239187 @default.
• W1900410293 hasAuthorship W1900410293A5035662512 @default.
• W1900410293 hasAuthorship W1900410293A5042040126 @default.
• W1900410293 hasAuthorship W1900410293A5043839163 @default.
• W1900410293 hasAuthorship W1900410293A5049281397 @default.
• W1900410293 hasAuthorship W1900410293A5049641939 @default.
• W1900410293 hasAuthorship W1900410293A5061145127 @default.
• W1900410293 hasAuthorship W1900410293A5063425002 @default.
• W1900410293 hasAuthorship W1900410293A5070038178 @default.
• W1900410293 hasAuthorship W1900410293A5071335044 @default.
• W1900410293 hasAuthorship W1900410293A5076722892 @default.
• W1900410293 hasAuthorship W1900410293A5083608720 @default.

• next